東方精工(002611.SZ)與雲印公司簽署戰略合作協議
格隆匯 7 月 19日丨東方精工(002611.SZ)發佈公告,東方精工於2020年7月18日與雲印公司簽署了《戰略合作協議》。雙方本着平等、自願、互利、共贏的原則,聚合雙方優質資源,建立長期合作關係,共同推動印刷包裝產業數字化轉型升級。
本次簽署的合作協議為意向性框架協議,不涉及具體金額,本協議的簽署無需提交公司董事會和股東大會審議。本協議的後續落地實施過程後若涉及具體金額,公司將嚴格按照相關部門規章、規範性文件和東方精工《公司章程》規定,履行相應的決策和審批程序。本協議的簽署公司無需履行相關部門備案審批程序。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.